tolbutamide has been researched along with hydroxyphenytoin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkett, DJ; Miners, JO; Pass, MC; Tassaneeyakul, W | 1 |
| Lin, JH; Lin, Y; Rodrigues, AD; Tang, C | 1 |
| Gorman, LA; Kumar, V; Rock, DA; Tracy, TS; Wahlstrom, JL; Warren, CJ | 1 |
1 trial(s) available for tolbutamide and hydroxyphenytoin
| Article | Year |
|---|---|
Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo.
Topics: Adult; Anticonvulsants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biomarkers; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Female; Humans; Hypoglycemic Agents; Male; Phenytoin; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tolbutamide | 1996 |
2 other study(ies) available for tolbutamide and hydroxyphenytoin
| Article | Year |
|---|---|
Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding.
Topics: Humans; In Vitro Techniques; Microsomes, Liver; Phenytoin; Protein Binding; Serum Albumin, Bovine; Tolbutamide | 2002 |
CYP2C9 inhibition: impact of probe selection and pharmacogenetics on in vitro inhibition profiles.
Topics: Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C9; Diclofenac; Enzyme Inhibitors; Flurbiprofen; Genotype; In Vitro Techniques; Pharmacogenetics; Phenytoin; Piroxicam; Tolbutamide; Warfarin | 2006 |